Table 1. Antibodies used in this study.
Antigen | Structure | mAb | Reference |
---|---|---|---|
Gb3 | Galα1,4Galβ1,4Glcβ-Cer | 38.13 | [26] |
Gb4 | GalNAcβ1,3Galα1,4Galβ1,4Glcβ-Cer | HIRO 34 | [26] |
Gb5 | Galβ1,3GalNAcβ1,3Galα1,4Galβ1,4Glcβ-Cer | 5A3 | [27] |
MSGG | Galβ1,3GalNAcβ1,3Galα1,4Galβ1,4Glcβ-Cer | RM1 | [24] |
3 | Raft2 | [25] | |
| | |||
NeuAcα2 | |||
DSGG | Galβ1,3GalNAcβ1,3Galα1,4Galβ1,4Glcβ-Cer | 5F3 | [22] |
36 | |||
| | | |||
NeuAcα2 NeuAcα2 |